Merck, Portola in $470M deal for anticlotting drug

Merck & Co. and Portola Pharmaceuticals Inc. said Thursday they have signed an exclusive deal to develop and market an experimental drug to prevent strokes in people with a dangerous irregular heart rhythm.

Copyright PHILY - Philly.com
Local U.S. and World Politics Weather Weather Alerts School Closings See It, Share It Sports Phillies Eagles Sixers Flyers NBC Sports Philadelphia Investigators NBC10 Responds Submit a tip Watch The Lineup Philly Live Entertainment Wawa Welcome America
About NBC10 Philadelphia Our News Standards Share a News Tip or Feedback Share a Consumer Complaint Share Photos and Video Community NBC Sports Philadelphia Our Apps Newsletters Contests Cozi TV
Contact Us